Kidney Cancer

Publications

  1. Management of Renal Masses and Localized Renal Cancer: Systematic Review and Meta-analysis.
    Authors: Pierorazio PM, Johnson MH, Patel HD, Sozio SM, Sharma R, Iyoha E, Bass EB, Allaf ME.
    Journal: Journal of Urology May, 2016
  2. Recent advances in immunotherapy for kidney cancer.
    Authors: Ball MW, Allaf ME, Drake CG.
    Journal: Discov Med 2016
  3. A Prospective, Comparative Study of Quality of Life among Patients with Small Renal Masses choosing Active Surveillance and Primary Intervention.
    Authors: Patel HD, Riffon MF, Joice GA, Johnson MH, Chang P, Wagner AA, McKiernan JM, Trock BJ, Allaf ME, Pierorazio PM.
    Journal: Journal of Urology April, 2016
  4. Circulating Tumor DNA as a Marker of Therapeutic Response in Patients With Renal Cell Carcinoma: A Pilot Study.
    Authors: Ball MW, Gorin MA, Guner G, Pierorazio PM, Netto G, Paller CJ, Hammers HJ, Diaz LA, Allaf ME
    Journal: Clin Genitourin Cancer 2016
  5. Diagnostic Accuracy and Risks of Biopsy in the Diagnosis of a Renal Mass Suspicious for Localized Renal Cell Carcinoma: Systematic Review of the Literature.
    Authors: Patel HD, Johnson MH, Pierorazio PM, Sozio SM, Sharma R, Iyoha E, Bass EB, Allaf ME.
    Journal: Journal of Urology February 18, 2016
  6. Management of Renal Masses and Localized Renal Cancer. Comparative Effectiveness Review No. 167. (Prepared by the JHU Evidence-based Practice Center under Contract No. 290-2012-00007-I.) AHRQ Publication No. 16-EHC001-EF.
    Authors: Pierorazio PM, Johnson MH, Patel HD, Sozio SM, Sharma R, Iyoha E , Bass EB, Allaf ME.
    Journal: Agency for Healthcare Research and Quality February, 2016
  7. Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry.
    Authors: Pierorazio PM, Johnson MH, Ball MW, Gorin MA, Trock BJ, Chang P, Wagner AA, McKiernan JM, Allaf ME.
    Journal: European Urology September, 2015
  8. Prospective Evaluation of (99m)Tc-sestamibi SPECT/CT for the Diagnosis of Renal Oncocytomas and Hybrid Oncocytic/Chromophobe Tumors.
    Authors: Gorin MA, Rowe SP, Baras AS, Solnes LB, Ball MW, Pierorazio PM, Pavlovich CP, Epstein JI, Javadi MS, Allaf ME.
    Journal: European Urology September 18, 2015
  9. Extent of Renal Vein Invasion Influences Prognosis in Patients with Renal Cell Carcinoma.
    Authors: Ball MW, Gorin MA, Harris KT, Curtiss KM, Netto GJ, Pavlovich CP, Pierorazio PM, Allaf ME.
    Journal: BJU Int 2015
  10. Preoperative predictors of malignancy and unfavorable pathology for clinical T1a tumors treated with partial nephrectomy: a multi-institutional analysis.
    Authors: Ball MW, Gorin MA, Bhayani SB, Rogers CG, Stifelman MD, Kaouk JH, Zargar H, Marshall S, Larson JA, Rahbar HM, Trock BJ, Pierorazio PM, Allaf ME.
    Journal: Seminars in Urologic Oncology March, 2015
  11. Initial Experience Using 99mTc-MIBI SPECT/CT for the Differentiation of Oncocytoma From Renal Cell Carcinoma.
    Authors: Rowe, Steven P. MD, PhD; Gorin, Michael A. MD; Gordetsky, Jennifer MD; Ball, Mark W. MD; Pierorazio, Phillip M. MD; Higuchi, Takahiro MD, PhD; Epstein, Jonathan I. MD; Allaf, Mohamad E. MD; Javadi, Mehrbod S. MD
    Journal: Clinical Nuclear Medicine January, 2015
  12. Grade heterogeneity in small renal masses: potential implications for renal mass biopsy.
    Authors: Ball MW, Bezerra SM, Gorin MA, Cowan M, Pavlovich CP, Pierorazio PM, Netto GJ, Allaf ME.
    Journal: J Urol 2015

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved. Disclaimer
Email: webmaster@urology.jhu.edu | 600 North Wolfe Street, Baltimore, Maryland 21287

urology second opinion urology second opinion